SPRY
ARS Pharmaceuticals Inc.
$9.65
-$0.25(-2.53%)
55
Overall
50
Value
83
Tech
34
Quality
Market Cap
$888.65M
Volume
2.28M
52W Range
$6.66 - $18.90
Target Price
$28.00
Company Overview
| Mkt Cap | $888.65M | Price | $9.65 |
| Volume | 2.28M | Change | -2.53% |
| P/E Ratio | -5.2 | Open | $10.05 |
| Revenue | $84.3M | Prev Close | $9.90 |
| Net Income | $-171.3M | 52W Range | $6.66 - $18.90 |
| Div Yield | N/A | Target | $28.00 |
| Overall | 55 | Value | 50 |
| Quality | 34 | Technical | 83 |
No chart data available
About ARS Pharmaceuticals Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRY | $9.65 | -2.5% | 2.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ARS Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW